Caffinity is a relatively new energy ingredient from FutureCeuticals made from arabica coffee fruit, combining naturally occurring caffeine and polyphenols in a single standardized complex. The company has been positioning it as a more complete alternative to traditional caffeine ingredients, and it has now strengthened that position with the publication of a new clinical study conducted by researchers at the University of Exeter in the United Kingdom.
The double-blind, placebo-controlled study evaluated 286mg of Caffinity, providing 200mg of caffeine alongside coffee fruit polyphenols, in cyclists. Results showed a nearly 5% increase in total work performed during a time trial, lower perceived exertion during steady-state exercise, greater fat mobilization and ketone availability during recovery, improved blood glucose stability, and faster lactate clearance despite higher overall performance output.
The findings suggest Caffinity delivers more than the typical energy and performance benefits associated with caffeine alone. It further strengthens the case for the premium ingredient for inclusion in energy and performance-fueled supplements, like pre-workouts and even energy drinks. You can check out the complete press release from Futureceuticals through prnewswire.com and read through the complete published study over on tandfonline.com.
